Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

GLOBOCAN 2022

VIET NAM
Number of new cases Number of deaths Number of prevalent cases
(5-year)

180 480 120 184 409 144


Statistics at a glance, 2022
Males Females Both sexes
Population 49 411 162 49 542 373 98 953 535

Incidence* Viet Nam

Number of new cancer cases 95 358 85 122 180 480

Age-standardized incidence rate 177.1 132.3 150.8

Risk of developing cancer before the age 18.8 13.7 16.0


of 75 years (cum. risk %)

Top 3 leading cancers (ranked by Liver Breast Breast


cases)**
Lung Lung Liver
Stomach Colorectum Lung

Mortality*

Number of cancer deaths 71 385 48 799 120 184

Age-standardized mortality rate 132.6 72.7 99.0

Risk of dying from cancer before the age 14.3 8.0 10.9
of 75 years (cum. risk %)

Top 3 leading cancers (ranked by Liver Breast Liver


deaths)**
Lung Lung Lung
Stomach Liver Stomach

Prevalence* Kilometers

0 250 500 1000

5-year prevalent cases 189 429 219 715 409 144

Top 5 most frequent cancers**

Males Females Both sexes


Breast
Liver

Breast

Others
Others Others Liver

Lung

Lung
Lung

Prostate
Stomach Liver Colorectum
Colorectum Stomach Colorectum
Stomach

Total: 95 358 Total: 85 122 Total: 180 480

Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent

1st Liver 18 952 19.9% 1st Breast 24 563 28.9% 1st Breast 24 563 13.6%

2nd Lung 17 007 17.8% 2nd Lung 7 419 8.7% 2nd Liver 24 502 13.6%

3rd Stomach 10 062 10.6% 3rd Colorectum 7 402 8.7% 3rd Lung 24 426 13.5%

4th Colorectum 9 433 9.9% 4th Stomach 6 215 7.3% 4th Colorectum 16 835 9.3%

5th Prostate 5 875 6.2% 5th Liver 5 550 6.5% 5th Stomach 16 277 9.0%

- Others 34 029 35.7% - Others 33 973 39.9% - Others 73 877 40.9%

Number of new cases in 2022, males, all ages Number of new cases in 2022, females, all ages Number of new cases in 2022, both sexes, all ages

The Global Cancer Observatory | All rights reserved | February, 2024 Page 1
Incidence, Mortality and Prevalence by cancer site

New cases Deaths 5-year prevalence

Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000)

Breast 24 563 1 38.0 4.1 10 008 4 14.7 1.6 72 617 17.7

Liver 24 502 2 20.2 2.4 23 333 1 19.3 2.3 33 191 8.1

Lung 24 426 3 20.3 2.5 22 597 2 18.7 2.3 34 477 8.4

Colorectum 16 835 4 13.9 1.7 8 454 5 6.8 0.80 46 140 11.3

Stomach 16 277 5 13.4 1.6 13 264 3 10.9 1.3 25 458 6.2

Thyroid 6 122 6 5.2 0.51 858 21 0.71 0.08 19 813 4.8

Prostate 5 875 7 11.5 1.3 2 800 9 5.4 0.32 12 411 3.0

Leukaemia 5 789 8 5.7 0.49 4 330 6 4.0 0.38 17 099 4.2

Nasopharynx 5 613 9 4.7 0.52 3 453 8 2.9 0.34 16 007 3.9

Corpus uteri 4 953 10 7.8 0.93 1 374 13 2.1 0.25 16 639 4.1

Cervix uteri 4 612 11 7.1 0.80 2 571 10 3.8 0.46 13 157 3.2

Oesophagus 3 686 12 3.1 0.37 3 470 7 2.9 0.35 5 752 1.4

NHL 3 516 13 3.0 0.34 2 211 12 1.9 0.21 10 591 2.6

Brain CNS 2 829 14 2.6 0.25 2 431 11 2.1 0.22 9 849 2.4

Lip, oral cavity 2 449 15 2.0 0.24 1 279 14 1.0 0.12 6 742 1.6

Hypopharynx 2 374 16 2.0 0.23 1 236 15 1.0 0.11 4 618 1.1

Kidney 2 246 17 2.0 0.21 1 112 18 0.97 0.10 6 580 1.6

Larynx 2 186 18 1.8 0.21 1 233 16 0.98 0.11 6 403 1.6

Bladder 1 972 19 1.6 0.19 1 004 19 0.78 0.09 5 785 1.4

Ovary 1 534 20 2.5 0.27 1 003 20 1.6 0.19 4 293 1.0

Pancreas 1 251 21 1.0 0.12 1 226 17 1.0 0.12 1 414 0.35

Oropharynx 700 22 0.58 0.07 372 23 0.30 0.04 1 917 0.47

Hodgkin lymphoma 613 23 0.57 0.05 228 25 0.20 0.02 1 959 0.48

Multiple myeloma 607 24 0.50 0.06 562 22 0.46 0.06 1 643 0.40

Salivary glands 417 25 0.35 0.04 169 27 0.14 0.01 1 244 0.30

Penis 413 26 0.74 0.08 152 28 0.28 0.03 1 213 0.30

Mesothelioma 342 27 0.29 0.03 289 24 0.24 0.03 559 0.14

Gallbladder 293 28 0.23 0.03 209 26 0.17 0.02 427 0.10

Testis 261 29 0.51 0.04 62 32 0.13 0.01 894 0.22

Melanoma 200 30 0.16 0.02 122 29 0.09 0.01 613 0.15

Vulva 188 31 0.28 0.03 73 31 0.10 0.01 524 0.13

Kaposi sarcoma 165 32 0.14 0.01 94 30 0.08 0.01 374 0.09

All cancers 180 480 - - 16.0 120 184 - - 10.9 409 144 -

All cancers excl. NMSC 179 123 - - 15.9 119 694 - - 10.9 404 986 -

Data source and methods


Incidence Incidence Mortality Males Females

Country-specific data source: Hanoi City cancer registry, Ho Breast 38.0 14.7 Breast 38.0

Chi Minh cancer registry 20.3 18.7 34.9 8.2


Lung Liver

Method: Weighted/simple average of the most recent sub-


Liver 20.2 19.3 Lung 31.5 11.0
national rates applied to 2022 population
Colorectum 13.9 6.8 Stomach 18.6 9.2

Mortality Stomach

Prostate
13.4

11.5 5.4
10.9 Colorectum

Prostate
17.5

11.5
11.0

Country-specific data source: No data Corpus uteri 7.8 2.1 Corpus uteri 7.8

Method: Estimated from national mortality estimates by


Cervix uteri 7.1 3.8 Cervix uteri 7.1
modelling, using mortality:incidence ratios derived from survival
Leukaemia 5.7 4.0 Nasopharynx 7.1 2.5
estimation

Thyroid 5.2 0.7 Leukaemia 6.1 5.4

Prevalence Nasopharynx 4.7 2.9 Oesophagus 5.9 0.6

Oesophagus 3.1 2.9 NHL 3.7 2.4

Computed using sex-; site- and age-specific incidence to 1-;3-


NHL 3.0 1.9 Hypopharynx 3.5 0.6
and 5-year prevalence ratios from Nordic countries for the period

Brain CNS 2.6 2.1 Lip, oral cavity 3.4 0.8


(2011-2020), and scaled using Human Development Index (HDI)

ratios. Ovary 2.5 1.6 Larynx 3.4 0.4

50 40 30 20 10 0 10 20 30 40 50 50 40 30 20 10 0 10 20 30 40 50

ASR (World) incidence and mortality rates, top 15 cancers** ASR (World) incidence rates per sex, top 15 cancers**

Page 2

* includes non-melanoma skin cancer (NMSC)

** NMSC included in other cancers

Age standardization using world population (see link)

References
Cancer incidence and mortality data
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020:

Website citation GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.

2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338.


Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).

Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020:
from: https://gco.iarc.who.int/today, accessed [DD Month YYYY].
An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.

© IARC 1965-2024 | All Rights Reserved | https://gco.iarc.who.int | https://gco.iarc.who.int/today

You might also like